Liqiang Duan
-
- Cancer-related molecular mechanisms research 2
- Cancer, Hypoxia, and Metabolism 1
-
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 1
-
- RNA modifications and cancer 6
- RNA Research and Splicing 4
- Extracellular vesicles in disease 1
-
- Immune Cell Function and Interaction 3
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Nature Communications (1 paper)Cancer Research (1 paper)
- Partner nations
- China
In The Last Decade
Liqiang Duan
13 papers receiving 112 citations
Peers
Comparison fields: 5 of 36
- Cancer Research 49
- Oncology 37
- Molecular Biology 82
- Immunology 20
- Cell Biology 9
Countries citing papers authored by Liqiang Duan
This map shows the geographic impact of Liqiang Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqiang Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqiang Duan more than expected).
Fields of papers citing papers by Liqiang Duan
This network shows the impact of papers produced by Liqiang Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqiang Duan. The network helps show where Liqiang Duan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liqiang Duan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 11 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 9 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 13 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 11 | |
| 14 | 2018 | 39 |
About Liqiang Duan
Liqiang Duan is a scholar working on Oncology, Cancer Research and Immunology, having authored 14 papers that have together received 112 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), RNA Research and Splicing (4 papers), Immune Cell Function and Interaction (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer-related molecular mechanisms research (2 papers), Extracellular vesicles in disease (1 paper), CAR-T cell therapy research (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Cancer Research (49 citations), Oncology (37 citations) and Molecular Biology (82 citations). Liqiang Duan has collaborated with scholars based in China. Frequent co-authors include Yinmin Gu, Shan Gao, Bai Cui, Fei Peng, Dong‐Yan Jin, Yajuan Liu, Bingcheng Lin, Yongbo Pan, Tianyou Cheng and Shun Wu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.